ALDEYRA THERAPEUTICS INC
ALDXNASDAQ🏆 #3428 by market capEarnings Nov 2US Equity
$1.51▲ $0.00 (+0.00%)
Market closed · at close1h—
24h▲ 0.0%
7d▼ 6.2%
14d▼ 6.5%
30d▼ 21.8%
1y▼ 71.8%
🏦Market Cap
$91M
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
—
Otter Score
52
Weak
📊
Analyst Ratings
Price
$1.51
Total
19
Raised
0
Lowered
1
Avg PT
$9.67
H / L
$12 / $7
| Institution | Action | Rating | Date |
|---|---|---|---|
HC Wainwright & Co. | Downgraded | Buy → Neutral | 2026-03-18 |
BTIG | Reiterated | Buy | 2025-11-10 |
Oppenheimer | Reiterated | Outperform | 2024-05-06 |
Citigroup | Reiterated | Buy | 2023-10-17 |
SVB Leerink | Reiterated | Outperform | 2021-12-21 |
Berenberg | Reiterated | Buy | 2020-12-16 |
Jefferies | Reiterated | Buy | 2020-10-30 |
Stifel Nicolaus | Reiterated | Buy | 2018-09-26 |
Stifel | Reiterated | Buy | 2018-09-26 |
Janney Capital | Reiterated | Buy | 2018-09-13 |
Seaport Global | Reiterated | Buy | 2018-01-26 |
Cantor Fitzgerald | Reiterated | Overweight | 2017-10-25 |
Canaccord Genuity | Reiterated | Buy | 2017-09-13 |
H.C. Wainwright | Reiterated | Buy | 2016-09-26 |
Cowen & Co. | Reiterated | Outperform | 2015-09-08 |
Chardan Capital | Reiterated | Buy | 2015-03-25 |
Laidlaw & Co. | Reiterated | Buy | 2015-01-26 |
Ascendiant Capital | Reiterated | Buy | 2014-12-03 |
Aegis Capital | Reiterated | Buy | 2014-06-19 |
One row per institution, most recent rating